NCT Number: NCT03299153
The Effects of Barberry Juice Consumption in Patients With Type 2 Diabetes
The aim of this study was to investigate the effect of barberry juice (BJ) as a natural antioxidant, on cardiovascular risk factors in patients with type 2 diabetes (T2DM). In a randomized clinical trial study, 46 T2DM patients, 30-70 years old recruited from "Diabetes Association of Iran-Babul ". Patients were randomly allocated to either the BJ group (n=23) who consumed 200 ml of BJ daily for eight weeks, or the control group (n=23) with no intervention. At the baseline and the end of 8-week intervention, blood pressure and biochemical markers were conducted.
Looking for future studies?
Notify MeKey information
Conditions
Age range
30 year–70 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Phase 4
Who can participate
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Fasting blood glucose>100 mg/dL (5.6 mmol /L)
- Systolic blood pressure>130 mmHg or diastolic blood pressure>85mmHg
- Triglycerides> 150 mg/dL (1.7 mmol/L)
Exclusion criteria
- taking insulin
- smoking
- using antioxidant supplements
Treatment and study plan
Primary outcomes
-
fasting blood glucose
Time frame: 8 weeks
-
total cholesterol
Time frame: 8 weeks
Secondary outcomes
-
LDL- cholesterol
Time frame: 8 weeks
-
HDL- cholesterol
Time frame: 8 weeks
-
Triglyceride
Time frame: 8 weeks
-
HbA1c
Time frame: 8 weeks
-
Systolic BP
Time frame: 8 weeks
-
Diastolic BP
Time frame: 8 weeks
Sponsors and collaborators
Lead sponsor
National Nutrition and Food Technology Institute
Other
Registry information
Official study title
The Effects of Barberry Juice Consumption on Glycaemic Control, Lipid Profile, Blood Pressure and Oxidative Stress in Patients With Type 2 Diabetes: A Randomized Clinical Trial
Important dates
- Study start
- 2016
- Primary completion
- 2017
- Study completion
- 2017
- First posted
- Oct 2, 2017
- Registry last updated
- Oct 2, 2017
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
A Study of Retatrutide (LY3437943) in Participants With Type 2 Diabetes Mellitus Who Have Obesity or Overweight
NCT05929079
Apnea, Body Weight
Anniston, Alabama, United States
View Trial DetailsA Study of HRS9531 Versus Semaglutide Once Weekly as Add-on Therapy to Metformin Monotherapy or in Combination With SGLT2 Inhibitors in Participants With Type 2 Diabetes
NCT06649344
Diabetes Mellitus, Diabetes Mellitus, Type 2
Tianjin, Tianjin Municipality, China
View Trial DetailsEfficacy of Once Weekly Semaglutide in Patients With Type 2 Diabetes: a Non Randomized Clinical Trial
NCT07732218
Diabetes Mellitus, Diabetes Mellitus, Type 2
Peshawar, Khyber Pakhtunkhwa, Pakistan
View Trial DetailsmHealth Intervention to Increase Physical Activity in Prediabetes and Type 2 Diabetes
NCT05351359
Diabetes Mellitus, Diabetes Mellitus, Type 2
Prague, Czechia
View Trial Details